Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

NCT01326559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Docetaxel, Cisplatin, 5-FU and Cetuximab

Sponsor

Hong Kong Nasopharyngeal Cancer Study Group Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]